398 related articles for article (PubMed ID: 8933891)
1. The early effect of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhinitis.
Kinikli G; Tülek N; Sentürk T; Turgay M; Tutkak H; Duman M; Tokgöz G
Allergol Immunopathol (Madr); 1996; 24(2):65-9. PubMed ID: 8933891
[TBL] [Abstract][Full Text] [Related]
2. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
3. T cell responses to the major allergen from the house dust mite Dermatophagoides pteronyssinus, Antigen P1: comparison of patients with asthma, atopic dermatitis, and perennial rhinitis.
Rawle FC; Mitchell EB; Platts-Mills TA
J Immunol; 1984 Jul; 133(1):195-201. PubMed ID: 6609976
[TBL] [Abstract][Full Text] [Related]
4. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in allergic rhinitis.
Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
[TBL] [Abstract][Full Text] [Related]
6. Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis.
Okano M; Otsuki N; Azuma M; Fujiwara T; Kariya S; Sugata Y; Higaki T; Kino K; Tanimoto Y; Okubo K; Nishizaki K
Clin Exp Allergy; 2008 Dec; 38(12):1891-900. PubMed ID: 19016801
[TBL] [Abstract][Full Text] [Related]
7. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
[TBL] [Abstract][Full Text] [Related]
8. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Immunology; 2005 Sep; 116(1):103-11. PubMed ID: 16108822
[TBL] [Abstract][Full Text] [Related]
9. Short-term efficacy of nasal immunotherapy.
Palma-Carlos AG; Santos AS; Pregal A
Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
[TBL] [Abstract][Full Text] [Related]
10. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy is effective in the treatment of allergic rhinitis. Retrospective study of 67 cases].
Bleda C; Soler R; Romaguera A; Mas S; Juan JM
Acta Otorrinolaringol Esp; 1998; 49(5):369-72. PubMed ID: 9717325
[TBL] [Abstract][Full Text] [Related]
12. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
13. [Grounds for treatment of patients with infectious-allergic rhinitis with bacterial allergens].
Baranova NI; Pochinina NK; Kostina EM
Vestn Otorinolaringol; 2005; (6):18-20. PubMed ID: 16353002
[TBL] [Abstract][Full Text] [Related]
14. [Effect of immunotherapy on selected immunologic indices in children with pollinosis].
Boznański A; Pirogowicz I; Widerska A; Hebrowska A
Pediatr Pol; 1996 Jan; 71(1):15-8. PubMed ID: 8966061
[TBL] [Abstract][Full Text] [Related]
15. Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells.
Glück J; Rogala B; Rogala E; Oleś E
Vaccine; 2007 Dec; 26(1):77-81. PubMed ID: 18054415
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte proliferative response to allergen in timothy sensitive patients and healthy persons.
Serov AA; Gushchin IS; Chitayeva VG
Allergol Immunopathol (Madr); 1984; 12(2):135-41. PubMed ID: 6464939
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
Wise SK; Schlosser RJ
Otolaryngol Clin North Am; 2012 Oct; 45(5):1045-54. PubMed ID: 22980684
[TBL] [Abstract][Full Text] [Related]
18. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
19. Sublingual specific immunotherapy reduces PBMC proliferations.
Fenoglio D; Puppo F; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Marseglia G; Ciprandi G
Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):147-51. PubMed ID: 15916016
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of allergic rhinitis].
Rasp G
Laryngorhinootologie; 1993 Aug; 72(8):373-8. PubMed ID: 8104404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
